0001715954-21-000001.txt : 20210310 0001715954-21-000001.hdr.sgml : 20210310 20210310163029 ACCESSION NUMBER: 0001715954-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210310 DATE AS OF CHANGE: 20210310 EFFECTIVENESS DATE: 20210310 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DTx Pharma, Inc. CENTRAL INDEX KEY: 0001715954 IRS NUMBER: 822009884 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-391787 FILM NUMBER: 21730166 BUSINESS ADDRESS: STREET 1: 3210 MERRYFIELD ROW CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-792-3601 MAIL ADDRESS: STREET 1: 3210 MERRYFIELD ROW CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: DTx Pharma, LLC DATE OF NAME CHANGE: 20170830 D 1 primary_doc.xml X0708 D LIVE 0001715954 DTx Pharma, Inc. 10655 Sorrento Valley Rd #100 SAN DIEGO CA CALIFORNIA 92121 (858) 223-6390 DELAWARE DTx Pharma, LLC Corporation true 2017 Arthur Suckow c/o DTx Pharma, Inc. 10655 Sorrento Valley Rd #100 San Diego CA CALIFORNIA 92121 Executive Officer Director John Rundy c/o DTx Pharma, Inc. 10655 Sorrento Valley Rd #100 San Diego CA CALIFORNIA 92121 Director Jeffrey Friedman c/o DTx Pharma, Inc. 10655 Sorrento Valley Rd #100 San Diego CA CALIFORNIA 92121 Executive Officer Director Andrew Adams c/o DTx Pharma, Inc. 10655 Sorrento Valley Rd #100 San Diego CA CALIFORNIA 92121 Director Matthew Hammond c/o DTx Pharma, Inc. 10655 Sorrento Valley Rd #100 San Diego CA CALIFORNIA 92121 Director Daniel Becker c/o DTx Pharma, Inc. 10655 Sorrento Valley Rd #100 San Diego CA CALIFORNIA 92121 Director Tim Scott c/o DTx Pharma, Inc. 10655 Sorrento Valley Rd #100 San Diego CA CALIFORNIA 92121 Director Niki Upper c/o DTx Pharma, Inc. 10655 Sorrento Valley Rd #100 San Diego CA CALIFORNIA 92121 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2021-02-26 false true false 0 100205523 100205508 15 Total amount sold includes $205,523.29 of cancellation of indebtedness and $99,999,985.24 of new cash. false 22 0 0 0 false DTx Pharma, Inc. /s/ Arthur Suckow Arthur Suckow Chief Executive Officer 2021-03-09